Moore B R, Krakowka S, Mcvey D S, Cummins J M, Robertson J T
Department of Clinical Sciences, College of Veterinary Medicine, Kansas State University, Manhattan 66506-5606, USA.
Equine Vet J. 1997 Mar;29(2):142-7. doi: 10.1111/j.2042-3306.1997.tb01656.x.
Protein and eicosanoid concentrations and procoagulant activity were determined in bronchoalveolar lavage fluid (BALF) from 32 Standardbred racehorses with inflammatory airway disease (IAD) and 6 control horses. Total protein, albumin and immunoglobulin G (IgG) concentrations were high (P < 0.05) in the BALF from horses with IAD, a finding consistent with exudation of plasma protein into the airway. Immunoglobulin A (IgA) concentrations also were increased (P < 0.05) which may signify local immunoglobulin production. Difference was not detected in prostaglandin E2 and 6-ketoprostaglandin F1 alpha concentrations in BALF of IAD-affected and control horses. Procoagulant activity was identified in the majority (66%) of BALF samples from IAD-affected horses and was not detected in control horses. Natural human interferon-alpha (nHulFN alpha) (placebo, 50, 150, or 450 units) was administered orally for 5 days to IAD-affected horses in a double-blind, randomised block design. Total protein, IgG, and IgA concentrations in BALF were reduced (P < 0.05) 8 days after administration of 50 u and 150 u nHuIFN alpha, and 15 days after administration of 50 u nHuIFN alpha. Procoagulant activity and albumin concentrations in BALF were lower 8 days after administration of 50 u nHuIFN alpha. Oral administration of low-dose nHuIFN alpha appeared to ameliorate these parameters of lower respiratory tract inflammation in Standardbred racehorses with IAD.
测定了32匹患有炎性气道疾病(IAD)的标准赛马和6匹对照马的支气管肺泡灌洗液(BALF)中的蛋白质、类花生酸浓度和促凝血活性。患有IAD的马的BALF中总蛋白、白蛋白和免疫球蛋白G(IgG)浓度较高(P<0.05),这一发现与血浆蛋白渗出到气道一致。免疫球蛋白A(IgA)浓度也有所增加(P<0.05),这可能表明局部免疫球蛋白的产生。在受IAD影响的马和对照马的BALF中,未检测到前列腺素E2和6-酮前列腺素F1α浓度的差异。在大多数(66%)受IAD影响的马的BALF样本中检测到促凝血活性,而在对照马中未检测到。采用双盲、随机区组设计,对受IAD影响的马口服天然人干扰素-α(nHulFNα)(安慰剂、50、150或450单位),持续5天。在给予50单位和150单位nHuIFNα后8天,以及给予50单位nHuIFNα后15天,BALF中的总蛋白、IgG和IgA浓度降低(P<0.05)。在给予50单位nHuIFNα后8天,BALF中的促凝血活性和白蛋白浓度较低。口服低剂量nHuIFNα似乎改善了患有IAD的标准赛马下呼吸道炎症的这些参数。